Logo image of COGT

COGENT BIOSCIENCES INC (COGT) Stock Analyst Ratings

NASDAQ:COGT - Nasdaq - US19240Q2012 - Common Stock

8.285  +0.09 (+1.04%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to COGT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.14. This target is 106.83% above the current price.
COGT was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about COGT.
In the previous month the buy percentage consensus was at a similar level.
COGT was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
COGT Historical Analyst RatingsCOGT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -80 -73 -66 -59 -52 -45 -38 -31 -24 -17 -10 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 8.2910.1016.8317.1424.15 - 21.91% 103.14% 106.83% 191.49%
COGT Current Analyst RatingCOGT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-01-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-12-11 Needham Downgrade Buy -> Hold
2024-12-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-10 Needham Reiterate Buy -> Buy
2024-12-09 Needham Reiterate Buy -> Buy
2024-11-14 JP Morgan Maintains Overweight -> Overweight
2024-11-13 Needham Maintains Buy -> Buy
2024-11-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-24 Needham Reiterate Buy -> Buy
2024-09-24 Citigroup Maintains Buy -> Buy
2024-09-05 Baird Maintains Neutral -> Neutral
2024-09-03 HC Wainwright & Co. Maintains Buy -> Buy
2024-08-07 Needham Reiterate Buy -> Buy
2024-08-07 JP Morgan Maintains Overweight -> Overweight
2024-06-27 Needham Reiterate Buy -> Buy
2024-06-17 Needham Reiterate Buy -> Buy
2024-06-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-24 Wedbush Reiterate Neutral -> Neutral
2024-05-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-08 Needham Reiterate Buy -> Buy
2024-02-27 JP Morgan Maintains Overweight -> Overweight
2024-02-26 Needham Reiterate Buy -> Buy
2024-02-26 Baird Downgrade Outperform -> Neutral
2024-02-26 Citigroup Maintains Buy -> Buy
2024-02-23 Wedbush Maintains Neutral -> Neutral
2024-02-12 Needham Reiterate Buy -> Buy
2024-02-08 Citigroup Initiate Buy
2023-12-15 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-11 Wedbush Downgrade Outperform -> Neutral
2023-12-08 JP Morgan Initiate Overweight